Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Alzheimer’s Drug Lecanemab Slows Cognitive Decline at Cost of Side-Effects, Shows Clinical Trial
Eisai and Biogen have shared the data from a phase III trial of their joint effort Alzheimer’s drug, lecanemab
Automation
Applied Mobile Technologies and Interfacing with Robotics Software: Developing Improved Approaches for Cleanrooms
With the automation of cleanrooms set to continue for the foreseeable future, considering best practice approaches for integrating mobile robotics in a pharma-compliant manner will be key for addressing the needs of the industry. This Insight article explores some of the potential obstacles to the adoption of mobile robotics and considers how they could be addressed.
Target Discovery
Accelerating Target Deconvolution for Therapeutic Antibody Candidates
Target deconvolution is crucial to the phenotypic discovery process. Jenny Mattsson of BioInvent International explains how using CRISPR/Cas9 screening is a more efficient target deconvolution approach.
Small Molecule Targets Toxic RNA Linked to ALS and Dementia
A UF Scripps Biomedical Research team have developed an RNA-targeting blood-brain penetrant small molecule to tackle genetic cases of ALS and dementia.
Pharma Data
Data Management Strategies of Tomorrow: Bridging the Gap Between Retired Data Systems and Digital Innovation
Key opinion leaders from AbbVie, Genentech, and the University of Southampton ask, “how and why must we change the way we work with data?”
Molecular Drug Design
mRNA Vaccine Development to Get a Quantum Boost
Moderna will partner with IBM to deploy next-generation technologies such as quantum computing to optimise mRNA medicines.
Top 3 Must-See Presentations: Discovery US 2022
Find out what you can't miss at Discovery US: In Person 2022...
Target Discovery
Expanding the Druggable Toolbox: Improving Access to Undruggable Targets
In this Commentary article, we explore the innovative approaches towards drug target identification being championed by Cambridge-based biotechnology company PhoreMost. Identifying new druggable targets may help to address a range of unmet diseases.
Automation
Lab Digitalisation: Automation, Transformation, and the Smart Labs of the Future
The quality control labs of the future have been envisioned as fully-integrated environments, automated through the capture of data in real-time. By developing labs with digital output in mind, researchers at all scales can plan for the future and refine their approach to lab digitalisation.
Medicinal Chemistry
Mcule: Compound Sourcing Expert
Mcule is a leading chemical marketplace for drug discovery where you can order small-molecule samples from a high-quality database. We acquire the compounds from the manufacturers and deliver them in a consolidated package, in the format specified by you
Target Discovery
Protein Linked to Increased Lung Cancer Survival
Evidence shows that targeting TLR2 with an agonist reduces lung tumour growth in mouse models.
Molecular Drug Design
Cortical Labs Secures $10M to Revolutionise AI with Biological Neurons
AI startup raises funds to advance commercialisation of groundbreaking biological intelligence operating system.